Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medicinova (MNOV) Accounts Payables (2021 - 2025)

Medicinova (MNOV) has disclosed Accounts Payables for 7 consecutive years, with $624995.0 as the latest value for Q4 2025.

  • On a quarterly basis, Accounts Payables changed N/A to $624995.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $624995.0, a N/A change, with the full-year FY2025 number at $624995.0, changed N/A from a year prior.
  • Accounts Payables was $624995.0 for Q4 2025 at Medicinova, down from $745958.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $1.0 million in Q4 2023 to a low of $402740.0 in Q4 2021.
  • A 5-year average of $647507.7 and a median of $642526.0 in 2021 define the central range for Accounts Payables.
  • Peak YoY movement for Accounts Payables: soared 55.38% in 2022, then dropped 14.71% in 2025.
  • Medicinova's Accounts Payables stood at $402740.0 in 2021, then soared by 37.24% to $552720.0 in 2022, then skyrocketed by 81.64% to $1.0 million in 2023, then fell by 29.46% to $708203.0 in 2024, then fell by 11.75% to $624995.0 in 2025.
  • Per Business Quant, the three most recent readings for MNOV's Accounts Payables are $624995.0 (Q4 2025), $745958.0 (Q3 2025), and $569445.0 (Q2 2025).